LY 2979165Alternative Names: LY2979165
Latest Information Update: 06 May 2016
At a glance
- Originator Eli Lilly
- Mechanism of Action Metabotropic glutamate receptor 2 agonists; Metabotropic glutamate receptor 3 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bipolar disorders
Most Recent Events
- 06 May 2016 Chemical structure information added
- 27 Apr 2016 Discontinued - Phase-I for Bipolar disorders (In volunteers) in Singapore & United Kingdom (PO)
- 23 Nov 2010 Phase-I clinical trials in Bipolar disorders in Singapore (PO)